Assessment of coenzyme q10 tolerability
β
Dr. A. Feigin; K. Kieburtz; P. Como; C. Hickey; D. Abwender; C. Zimmerman; K. St
π
Article
π
1996
π
John Wiley and Sons
π
English
β 273 KB
## Abstract We performed a 6βmonth openβlabel trial to evaluate the tolerability and efficacy of coenzyme Q10 (CoQ) in 10 patients with Huntington's disease (HD), Subjects were evaluated at baseline, 3 months, and 6 months using the HD Rating Scale (HDRS), the HD Functional Capacity Scale (HDFCS),